Zobrazeno 61 - 70
of 161
pro vyhledávání: ''
Autor:
Subramanian Nallasivan
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 57-60 (2019)
Osteoporosis is ever increasing as life expectancy continues to increase across the world. Hypovitaminosis D has been found to be prevalent even in children and adults, and hence, it is imperative to educate the public on the nutrition for bone healt
Autor:
Vijay Rao, Chandrashekara Srikantiah, Yogesh Preet Singh, Pradeep Kumar, Sharath Kumar, Vineeta Shobha, Anu Mohan Desai, BG Dharmanand, Uma Karjigi, Chethana Dharmapalaiah, Shiva Prasad, Manisha Ashwin Daware, Kurugodu Mathada Mahendranath, Ramesh Jois
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 17-20 (2019)
Introduction: Biologics are widely used in Autoimmune rheumatologic diseases (AIRDs), however the need to capture real life data which monitors indications, adverse reactions cannot be over emphasized. Methods: This is a cross-sectional ambidirection
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 4, Pp 283-289 (2019)
Background: Psoriasis is a common chronic, recurrent inflammatory skin disorder. Omega-3 fatty acids exhibit low inflammatory effects, while n-6 fatty acids display high inflammatory effects. The purpose of this preliminary study was to determine ery
Autor:
Raja Natarajan
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 2, Pp 145-150 (2019)
Psoriasis is a commonly encountered skin condition with a significant percentage of patients developing arthritis. Psoriasis is associated with multiple comorbid conditions. However, the association of interstitial lung disease (ILD) with psoriasis i
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 42-48 (2019)
Background: Rheumatic diseases have many outcomes, but less understood are many manifestations of additional health conditions that are associated with these diseases called co-morbidities. The more co-morbid illnesses one has, the greater the interf
Autor:
Andreina Teresa Manfredi, Rosario Foti, Roberta Ramonda, Stefano Alivernini, Roberto Caporali, Antonio Carletto, Francesco Paolo Cantatore, Roberto Gorla, Marco Sebastiani, Ennio Giulio Favalli, Giovanni Lapadula, Elisa Gremese, Antonio Marchesoni, Oscar Massimiliano Epis, Florenzo Iannone, Fausto Salaffi, Fabrizio Conti, Gianfranco Ferraccioli, Enrico Fusaro, Alessandra Bortoluzzi, Alberto Cauli, Luca Cantarini, Salvatore D'Angelo
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 4, Pp 271-276 (2019)
Objective: Despite the well-established efficacy of methotrexate (MTX) in rheumatoid arthritis (RA), monotherapy is not sufficient in almost half of patients. The aim of this registry-based study was to detect possible predictive factors for the earl
Autor:
Raval Dhiren, Bindroo Muzaffar, Rajiva Gupta, Tanna Dhaval, Sharma Lucky, Ekbote Gayatri, Negalur Natasha
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 12-16 (2019)
Background: Induction with cyclophosphamide (CYC) and glucocorticoids in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) has a relapse of 30%–50%. Studies show that rituximab (RTX) is superior to CYC in refractory/relapsed AAV. We p
Autor:
Sanjiv Kapoor, Anand N. Malaviya
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 3, Pp 186-194 (2018)
In a landmark breakthrough in 1976, Reichlin and Mattioli discovered the first myositis-specific antibody (MSA) called anti-Mi2 antibody that identified a specific clinical phenotype characterized by pathognomonic skin rash of dermatomyositis, typica
Autor:
Debasish Maikup, Nachiketa Mahapatra, Krishna Prasad Tripathy, Prasanta Padhan, Saroj Ranjan Sahoo
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 1, Pp 56-59 (2018)
Kikuchi–Fujimoto disease (KFD), or histiocytic necrotizing lymphadenitis, is a rare benign, self-limiting disorder of unknown etiology. Mostly prevalent among Asian women, KFD manifests mostly with cervical and rarely generalized or retroperitoneal
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 4, Pp 255-258 (2018)
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered the first-line drugs for axial spondyloarthritis because of their high efficacy in controlling symptoms. However, the review of the literature shows that among Caucasian patient